RH
Rajina Harischandran
About Rajina Harischandran
Data last updated:
Rajina Harischandran is a Designated Partner at Naura Pharma Llp (since 2022). The companies operate in Business Services and Pharma. Earlier, Rajina Harischandran was a Designated Partner at Pharvinex Life Science Llp (2015–2017) and Designated Partner at Pharvinex International Llp (2015–2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 02 Nov 2022 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 07 Oct 2015 | 2015 | ₹13.43 Cr (FY 2023) | Active | |
| Designated Partner | 20 Apr 2015 | 2015 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rajina Harischandran
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashwin Harischandran | 10026319 | Naura Pharma Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajina Harischandran
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajina Harischandran
Rajina Harischandran currently holds 1 directorship: Naura Pharma Llp (Designated Partner, since 02 Nov 2022).
Rajina Harischandran was first appointed on 20 Apr 2015 as Designated Partner at Pharvinex International Llp. The most recent appointment on record is 02 Nov 2022 at Naura Pharma Llp.
Rajina Harischandran held 2 earlier board appointments: Pharvinex Life Science Llp (Designated Partner, 07 Oct 2015 to 31 Mar 2017); Pharvinex International Llp (Designated Partner, 20 Apr 2015 to 31 Mar 2017).
The current boards of Rajina Harischandran's companies include Ashwin Harischandran (Naura Pharma Llp).